CADTH Reimbursement Review - Idecabtagene Vicleucel (Abecma) - Sponsor: Celgene Inc., a Bristol Myers Squibb Company

Canadian Agency for Drugs and Technologies in Health

Share artifact

Or copy link:

Register Login

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Accessing this content requires a membership

Check your affiliation Start a trial

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Add to list

You have no lists yet

Manage lists

Citation

Health, C., 2022. CADTH Reimbursement Review - Idecabtagene Vicleucel (Abecma) - Sponsor: Celgene Inc., a Bristol Myers Squibb Company, Canadian Agency for Drugs and Technologies in Health. Canada. Retrieved from https://canadacommons.ca/artifacts/2368604/cadth-reimbursement-review-idecabtagene-vicleucel-abecma-sponsor/3389619/ on 26 Apr 2024. CID: 20.500.12592/32rwrw.

Download citation (RIS)

Full-page Screenshot

Screenshot of https://coherent-commons.s3.amazonaws.com/artifacts/file/file/d4101f70-278a-49be-b3fc-e443e88ecaec.pdf?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA23B6R4NTCRHS5NZ3%2F20240426%2Fus-east-2%2Fs3%2Faws4_request&X-Amz-Date=20240426T090606Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=6a98e65236920c7ba9c5da8c5a09f7ee89ad306ecd49227d84e1e6ff3c9ef6b8

CADTH Reimbursement Review - Idecabtagene Vicleucel (Abecma) - Sponsor: Celgene Inc., a Bristol Myers Squibb Company

Authors